Report on the results of sale of securities (F53-5)
Name of Company
JPMORGAN SECURITIES (THAILAND) LIMITED
Date 10-Aug-2022
Maturity date
09-Aug-2022
DW symbol
Number of subscribed DW (unit)
ADVA41C2208A
0
AMAT41C2208A
0
AOT41C2208A
0
AOT41C2208B
0
AOT41P2208A
0
BCH41C2208A
0
BH41C2208A
0
COM741C2208A
0
CRC41C2208A
0
CRC41C2208B
0
DOHO41C2208A
0
DTAC41C2208A
0
EA41C2208A
0
EA41C2208B
0
EA41C2208C
0
GLOB41C2208A
0
GPSC41C2208A
0
GULF41C2208A
0
GULF41C2208B
0
GULF41P2208A
0
GUNK41C2208A
0
INTU41C2208A
0
IRPC41C2208A
0
IVL41C2208A
0
IVL41C2208B
0
JMAR41C2208A
0
JMT41C2208A
0
KCE41C2208A
0
KTC41C2208A
0
MEGA41C2208A
0
MINT41C2208A
0
MTC41C2208A
0
OSP41C2208A
0
PTG41C2208A
0
PTTE41C2208A
0
PTTE41P2208A
0
PTTG41C2208A
0
RBF41C2208A
0
SAWA41C2208A
0
SCC41C2208A
0
SPRC41C2208A
0
SYNE41C2208A
0
TOP41C2208A
0
TU41C2208A
0
Signature _________________
(Tosapol Kerdphol)
Assistant Director of Listed Structured Products Authorized to sign on behalf of the company
This announcement was prepared and disseminated by listed company or issuer through the electronic system
which is provided for the purpose of dissemination of the information and related documents of listed company or issuer to the Stock Exchange of Thailand only. The Stock Exchange of Thailand has no responsibility for the correctness and completeness of any statements, figures, reports or opinions contained in this announcement, and has no liability for any losses and damages in any cases. In case you have any inquiries or clarification regarding this announcement, please directly contact listed company or issuer who made this announcement.
Attachments
Original Link
Original Document
Permalink
Disclaimer
Bumrungrad Hospital pcl published this content on 10 August 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 10 August 2022 12:09:56 UTC.
Bumrungrad Hospital Public Company Limited is a healthcare provider in Thailand and Southeast Asia, providing holistic and healthcare services for both outpatients and inpatients. The Company operates through a hospital and health care center business. It operates a private hospital business in Bangkok with 580 licensed beds and a capacity for over 5,500 outpatients per day. Its Telemedicine service provides consultation through information technology to support remote access consultation. Its preventive genomics and family check-up services provide diagnosis, treatment, and advice, including risk assessment and screening for diseases caused by genetic abnormalities. Its Bumrungrad@Home service provides health care services for patients and families at their homes as necessary. Its Breast Center delivers holistic medical services regarding breast health for all genders. Its sports medicine and joint center offer an integrated approach to treating musculoskeletal problems.